A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are a first-line therapy for non-small cell lung cancer (NSCLC) with EGFR mutations. Approximately half of the patients with EGFR-muta...
Source: Cancer Imaging - Category: Radiology Authors: Chia-Feng Lu, Chien-Yi Liao, Heng-Sheng Chao, Hwa-Yen Chiu, Ting-Wei Wang, Yen Lee, Jyun-Ru Chen, Tsu-Hui Shiao, Yuh-Min Chen and Yu-Te Wu Tags: Research article Source Type: research
More News: Cancer | Cancer & Oncology | Chia | Learning | Lung Cancer | Non-Small Cell Lung Cancer | Radiology | Universities & Medical Training